Search
for
Sort by
Research 301–330 of 361
- Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Poster Presentations
- Developing Human Skin Contains Lymphocytes Demonstrating a Memory Signature
- Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- Responsive Microneedles as a New Platform for Precision Immunotherapy
- Extracellular Vesicles for Regenerative Medicine Applications
- Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme
- Long-acting microneedle formulations
- Stress-induced sympathetic hyperactivation drives hair follicle necrosis to trigger autoimmunity
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Review of Promising Off-Label Use of Deucravacitinib
- Endocrinology
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- A complete guide to human microbiomes: Body niches, transmission, development, dysbiosis, and restoration
- Macrophages in Skin Wounds: Functions and Therapeutic Potential
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Smart Responsive Microneedles for Controlled Drug Delivery
- Prophylaxis and Management of Skin Toxicities